Total revenue of $3.24 billion, down 5.7% (down 5.6% on an organic basis(1)) Diluted earnings per share was $0.23 vs. $0.49 in the prior year quarter; ...
Novozymes and Chr. Hansen have historically generated ample free cash flow and returned value to shareholders primarily through dividends. Management expects to continue to reward shareholders with a ...